Market: Zurich | Symbol: SIKA | ISIN: CH0418792922 | Industry: Building Materials & Fixtures |
Sika is a specialty chemicals company with a globally leading position in the development and production of systems and products for bonding, sealing, damping, reinforcing, and protection in the building sector and industrial manufacturing. Sika has subsidiaries in 102 countries around the world and, in over 400 factories, produces innovative technologies for customers worldwide. In doing so, it plays a crucial role in enabling the transformation of the construction and transportation sector toward greater environmental compatibility. With more than 34,000 employees, the company generated sales of CHF 11.76 billion in 2024.
ISIN | CH0418792922 |
WKN | 840400 |
Currency | CHF |
Volume (shares) | 455,984 |
Previous Close | 213.70 |
Number of Shares (mln) | 160.48 |
Change (%) | 0.23 |
Market Cap (mln) | 34,294.42 |
Friday, February 21, 2025 | Media conference/analyst presentation on full-year results 2024 |
Tuesday, March 25, 2025 | 57th Annual General Meeting |
Tuesday, April 15, 2025 | Net Sales First Quarter 2025 |
Tuesday, July 29, 2025 | Half-Year Report 2025 |
Friday, October 24, 2025 | Results first nine months 2025 |
Tuesday, January 13, 2026 | Net sales 2025 |
Silent period: January 31, 2025 - February 20, 2025
CHF mn | 2020 | 2021 | 2022 | 2023 | 2024 | ||
Income Statement | |||||||
Net sales | 7,878 | 9,252 | 10,492 | 11,239 | 11,763 | ||
Gross result | 4,315 | 4,791 | 5,180 | 6,025 | 6,416 | ||
as % of Net sales | 54.8 | 51.8 | 49.4 | 53.6 | 54.5 | ||
EBITDA | 1,498 | 1,758 | 1,964 | 2,045 | 2,270 | ||
as % of Net sales | 19.0 | 19.0 | 18.7 | 18.2 | 19.3 | ||
EBIT | 1,131 | 1,391 | 1,580 | 1,549 | 1,714 | ||
as % of Net sales | 14.4 | 15.0 | 15.1 | 13.8 | 14.6 | ||
Net profit | 825 | 1,049 | 1,163 | 1,063 | 1,248 | ||
as % of Net sales | 10.5 | 11.3 | 11.1 | 9.5 | 10.6 | ||
Balance Sheet | |||||||
Current assets | 3,635 | 4,166 | 5,021 | 4,205 | 4,563 | ||
Non-current assets | 6,159 | 6,541 | 6,298 | 10,844 | 11,414 | ||
Current liabilities | 1,825 | 2,096 | 2,041 | 3,415 | 2,585 | ||
Non-current liabilities | 4,681 | 4,215 | 4,311 | 5,701 | 6,345 | ||
Shareholders' equity | 3,288 | 4,396 | 4,967 | 5,933 | 7,047 | ||
Balance sheet total | 9,794 | 10,707 | 11,319 | 15,049 | 15,977 | ||
Cash Flow | |||||||
Free cash flow | 1,120 | 595 | 931 | -1,801 | 1,138 | ||
Operating free cash flow | 1,259 | 908 | 865 | 1,442 | 1,403 | ||
Key Ratios | |||||||
Equity ratio | 33.6 | 41.1 | 43.9 | 39.4 | 44.1 | ||
Net working capital as % of Net sales | 16.9 | 18.4 | 18.3 | 19.1 | 19.7 | ||
Return on capital employed (ROCE) (%) | 16.6 | 20.1 | 21.6 | 16.3 | 14.2 | ||
Return on equity (ROE) (%) | 25.1 | 23.9 | 23.4 | 17.9 | 17.7 |